Código QR (código de barras bidimensional)

Prevention of recurrent infection by fecal microbiota, live-jslm (REBYOTA) administered via colonoscopy: 6-month data from the single-arm phase IIIb CDI-SCOPE trial

Background: Fecal microbiota, live-jslm (RBL) is a microbiota-based product for the prevention of recurrent Clostridioides difficile infection (rCDI) in adults following antibiotic treatment. The safety and clinical effectiveness of RBL administered via colonoscopy in adults with rCDI were evaluated...

ver descrição completa

Na minha lista:
Principais autores: Sahil Khanna, David Yoho, Daniel Van Handel, Brian J. Clark, Tahany Awad, Beth Guthmueller, Daniel Armandi, Whitfield Knapple, Nasia Safdar, Brian Baggott, Karen Simon, Paul Feuerstadt
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publishing 2025-11-01
coleção:Therapeutic Advances in Gastroenterology
Acesso em linha:https://doi.org/10.1177/17562848251396744
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados